Adequan Injections For Dogs Uk

It has to be administered in a series of 8 injections.

Adequan injections for dogs uk.

The approved label dose of adequan canine is 02 ml per pound of body weight by intramuscular injection only twice weekly for up to four weeks maximum of eight injections. Just like any other injection one of the biggest perks of choosing adequan for dogs with arthritis problems is the fact that each injection will be quick and painless. The recommended adequan dose for dogs is 2 mg per lb of body weight given only by intramuscular im injection twice a week for up to 4 weeks a maximum of 8 injections. Administer twice weekly for up to 4 weeks maximum of 8 injections at approved dosage of 2 mg lb body weight 0 02 ml lb or 1 ml 50 lb by intramuscular im injection only.

It is made of repeat disaccharide units comprising hexosamine and hexuronic acid and is similar to glycosaminoglycans already present in the cartilage. We have no further studies or technical data supporting a use protocol beyond of the approved label dosing. Do not exceed the recommended dose or therapeutic regimen. Although improvement is generally observed after the second injection cartilage erosion ceases after the administration of all 8 injections.

Psag thus easily integrates. The recommended dose of adequan canine is 2 mg lb body weight 02 ml lb or 1 ml per 50 lb by intramuscular injection only twice weekly for up to 4 weeks maximum of 8 injections. This dose of adequan canine should be injected intramuscularly twice a week for 4 weeks. Polysulfated glycosaminoglycan psgag sold under the brand name adequan is an injectable drug for dogs and horses that is used to alleviate the lameness pain and lowered range of motion caused by arthritis.

Your veterinarian will determine the appropriate dose for your pet. Normally a course of 4 injections is given at 5 7 day intervals. The recommended dosage is 2mg per pound of the dog s weight. It has been found that it provides relief from pain stiffness and lameness as effectively as the non steroidal anti inflammatory drugs commonly used in veterinary medicine.

2 do not exceed the recommended dose or therapeutic regimen. Important safety information adequan canine should not be used in dogs who are hypersensitive to psgag or who have a known or suspected bleeding disorder. The most commonly reported side effects were mild pain or swelling at the injection site diarrhea and delayed blood clotting that did not require treatment. Use adequan canine early at the first clinical signs of oa before it progresses and cartilage is irreversibly damaged.

However note that adequan has not been tested on pregnant or nursing dogs and should be used with caution in dogs that have had liver or kidney transplants or have a history of bleeding. It should be used with caution in dogs with renal or hepatic impairment.